Matching articles for "Beyaz"
Issue 1676 · May 15, 2023
Choice of Contraceptives

Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also effective in…

Med Lett Drugs Ther. 2023 May 15; 65(1676):73-80 doi:10.58347/tml.2023.1676a
Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also effective in preventing pregnancy. When used alone, barrier and behavioral methods generally have higher failure rates than other methods (see Table 1). Selection of a contraceptive method is usually based on patient-specific factors and personal preference
Issue 1557 · October 8, 2018
Choice of Contraceptives

Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also highly…

Med Lett Drugs Ther. 2018 Oct 8; 60(1557):161-8
Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also highly effective in preventing pregnancy. When used alone, barrier and fertility-based methods generally have higher failure rates than other methods.
Issue 1477 · September 14, 2015
Choice of Contraceptives

Implants, intrauterine devices (IUDs), and sterilization are the most effective contraceptive methods available. Pills, patches, rings, and injectables, when used correctly, are also highly effective in…

Med Lett Drugs Ther. 2015 Sep 14; 57(1477):127-32
Implants, intrauterine devices (IUDs), and sterilization are the most effective contraceptive methods available. Pills, patches, rings, and injectables, when used correctly, are also highly effective in preventing pregnancy. Barrier and fertility-based methods have the highest rates of failure.
Issue 1389 · April 30, 2012 Free
In Brief: Warning about Drospirenone in Oral Contraceptives

The FDA has announced that combination hormonal contraceptives (CHCs) containing the synthetic progestin drospirenone ( Yaz, Yasmin, Beyaz, Safyral, and others) may be associated with a higher risk of…

Med Lett Drugs Ther. 2012 Apr 30; 54(1389):33
The FDA has announced that combination hormonal contraceptives (CHCs) containing the synthetic progestin drospirenone ( Yaz, Yasmin, Beyaz, Safyral, and others) may be associated with a higher risk of thromboembolism than CHCs containing other progestins. 1 The new warning was based partly on an unpublished, FDA-funded, retrospective study that found a 1.7-times higher risk of venous thromboembolism among US women who used a CHC that contained drospirenone than among women whose CHC contained levonorgestrel, norgestimate or norethindrone as the progestin component. 2 As with all retrospective studies, unknowable confounding factors, such as why doctors prescribed one progestin over the other, could have distorted the results. All CHCs increase the risk of venous thromboembolism; whether the progestin component affects the risk has been controversial. The Medical Letter and several other reviews and consensus statements have found no convincing evidence of an increased risk with drospirenone. 3-5 1. FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone. Available at www.fda.gov/Drugs/DrugSafety/ucm299305.htm. Accessed April 23, 2012. 2. FDA. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints. Available at www.fda.gov/downloads/Drugs/DrugSafety/ucm277384. Accessed April 23, 2012. 3. Combination oral contraceptives and the risk of venous thromboembolism. Med Lett Drugs Ther 2010; 52:23. 4. RL Reid. Oral contraceptives and venous thromboembolism: pill scares and public health. J Obstet Gynaecol Can 2011; 33:1150. 5. L Manzoli et al. Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis. Drug Saf 2012; 35: 191. Download complete U.S. English article
Issue 1353 · December 13, 2010 Free
In Brief: An Oral Contraceptive with Folate

Six years after an FDA advisory committee recommended development of a combination tablet containing an oral contraceptive and folic acid, 1 the FDA has approved Beyaz (Bayer), a combination of the oral…

Med Lett Drugs Ther. 2010 Dec 13; 52(1353):104
Six years after an FDA advisory committee recommended development of a combination tablet containing an oral contraceptive and folic acid, 1 the FDA has approved Beyaz (Bayer), a combination of the oral contraceptive Yaz 2 with 451 mcg of levomefolate calcium, the primary metabolite of folic acid. 3 According to the FDA, an unpublished double-blind, randomized U.S. trial in 379 healthy women 18-40 years old found that the combination increased serum folate levels. In an unpublished German study using a similar oral contraceptive/ levomefolate combination (summarized in the package insert), folate levels remained elevated for several weeks after levomefolate was stopped. 4 The standard US diet provides 50-500 mcg of absorbable folate per day, but the bioavailability of folate in mixed diets varies. Folic acid in supplements is more bioavailable than folate in food. 5 Supplementing the diet of women of childbearing age with 400 mcg of folic acid per day, the amount contained in most multivitamin preparations, has dramatically decreased the incidence of neural tube defects in their offspring.To effectively prevent neural tube defects, folic acid supplementation should be started at least one month before conception and continued through the first 2-3 months of pregnancy. Since incorrect or inconsistent use of oral contraceptives may account for as many as one million pregnancies in the US each year, all women capable of becoming pregnant should take a folic acid supplement. 6,7 1. Folic acid supplementation to prevent neural tube defects. Med Lett Drugs Ther 2004; 46:17. 2. Three new oral contraceptives. Med Lett Drugs Ther 2006; 48:77. 3. Choice of contraceptives. Treat Guidel Med Lett 2010; 8:89. 4. FDA approves combination contraceptive containing a folate. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm227237.htm. Accessed October 5, 2010. 5. GP Oakley, Jr. Eat right and take a multivitamin. N Engl J Med 1998; 338:1060. 6. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 150:626. 7. AM Kaunitz. Oral contraceptive use, pregnancy intendedness and folic acid intake. FDA Advisory Committee for Reproductive Health Drugs meeting; December 15, 2003; Gaithersburg, MD. Available at http://www.fda.gov/ohrms/dockets/ac/03/transcripts/4002T1.DOC. Accessed November 3, 2010. Download U.S. English
Issue 100 · December 1, 2010
Choice of Contraceptives

The choice of which contraceptive to use may vary from one stage of reproductive life to another. Intrauterine devices (IUDs), progestin implants and sterilization are the most effective contraceptive methods…

Treat Guidel Med Lett. 2010 Dec; 8(100):89-96
The choice of which contraceptive to use may vary from one stage of reproductive life to another. Intrauterine devices (IUDs), progestin implants and sterilization are the most effective contraceptive methods available to women. Hormonal contraceptives, when used correctly, are also highly effective in preventing pregnancy. Barrier and fertility-based methods have the highest rate of failure.